Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
This study is a community-informed, pragmatic, open-label, phase 1 clinical trial of group-format psilocybin-assisted therapy (GPAT) for individuals with post-traumatic stress disorder (PTSD). The primary objectives of this phase 1 study are to assess the safety and feasibility of (GPAT) for individuals with (PTSD) and to evaluate preliminary effects on PTSD severity.
- Status
- recruiting
- Phase
- Phase 1
- Institution
- University of New Mexico
- Start date
- 2026-05-01
- End date
- 2028-05-01
- Registry ID
- NCT07506395
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.